Hinge Health, Inc. (HNGE)
NYSE: HNGE · Real-Time Price · USD
43.11
+0.04 (0.09%)
At close: Jul 8, 2025, 4:00 PM
42.61
-0.50 (-1.16%)
After-hours: Jul 8, 2025, 7:58 PM EDT
Hinge Health Stock Forecast
Stock Price Forecast
The 12 analysts that cover Hinge Health stock have a consensus rating of "Strong Buy" and an average price target of $45.64, which forecasts a 5.87% increase in the stock price over the next year. The lowest target is $41 and the highest is $52.
Price Target: $45.64 (+5.87%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Hinge Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 |
|---|---|
| Strong Buy | 5 |
| Buy | 7 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Initiates $48 | Strong Buy | Initiates | $48 | +11.34% | Jun 16, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $41 | Buy | Initiates | $41 | -4.89% | Jun 16, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $48 | Strong Buy | Initiates | $48 | +11.34% | Jun 16, 2025 |
| Raymond James | Raymond James | Buy Initiates $45 | Buy | Initiates | $45 | +4.38% | Jun 16, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $46 | Buy | Initiates | $46 | +6.70% | Jun 16, 2025 |
Financial Forecast
Revenue This Year
n/a
from 390.40M
Revenue Next Year
n/a
EPS This Year
n/a
from -0.88
EPS Next Year
n/a
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.